Skip to main content

Table 4 Baseline cell-loss metric and pathologic outcome

From: Early prediction of pathologic response to neoadjuvant treatment of breast cancer: use of a cell-loss metric based on serum thymidine kinase 1 and tumour volume

Pathologic status

Quartile 1

Quartile 2

Quartile 3

Quartile 4

n (%)

n (%)

n (%)

n (%)

pCR*

3 (11.5)

3 (11.5)

6 (23.1)

12 (46.2)

pT1

7 (26.9)

11 (42.3)

13 (50.0)

7 (26.9)

pT2 + pT3

16 (61.5)

12 (46.2)

7 (26.9)

7 (26.9)

  1. *) pCR denotes pathological complete response in the breast
  2. Pathological status among 104 women with breast cancer grouped into four quartiles according to the TK1-based cell-loss metric at baseline